ESCMID Online Lecture Library. by author

Similar documents
Concise Antibiogram Toolkit Background

Understanding the Hospital Antibiogram

MICRONAUT MICRONAUT-S Detection of Resistance Mechanisms. Innovation with Integrity BMD MIC

Safe Patient Care Keeping our Residents Safe Use Standard Precautions for ALL Residents at ALL times

Summary of the latest data on antibiotic resistance in the European Union

Educating Clinical and Public Health Laboratories About Antimicrobial Resistance Challenges

EARS Net Report, Quarter

Antimicrobial Susceptibility Testing: Advanced Course

Florida Health Care Association District 2 January 13, 2015 A.C. Burke, MA, CIC

Workshop Summary and Action Items

RCH antibiotic susceptibility data

New Opportunities for Microbiology Labs to Add Value to Antimicrobial Stewardship Programs

ANTIMICROBIAL RESISTANCE SURVEILLANCE FROM SENTINEL PUBLIC HOSPITALS, SOUTH AFRICA, 2014

How is Ireland performing on antibiotic prescribing?

Surveillance of Antimicrobial Resistance and Healthcare-associated Infections in Europe

2012 ANTIBIOGRAM. Central Zone Former DTHR Sites. Department of Pathology and Laboratory Medicine

ADC 2016 Report on Bacterial Resistance in Cultures from SEHOS and General Practitioners in Curaçao

Protocol for Surveillance of Antimicrobial Resistance in Urinary Isolates in Scotland

UNDERSTANDING YOUR DATA: THE ANTIBIOGRAM

BACTERIAL SUSCEPTIBILITY REPORT: 2016 (January 2016 December 2016)

European Committee on Antimicrobial Susceptibility Testing

Antimicrobial Resistance Strains

European Committee on Antimicrobial Susceptibility Testing

Antimicrobial Resistance Surveillance from sentinel public hospitals, South Africa, 2013

The UK 5-year AMR Strategy - a brief overview - Dr Berit Muller-Pebody National Infection Service Public Health England

THE NAC CHALLENGE PANEL OF ISOLATES FOR VERIFICATION OF ANTIBIOTIC SUSCEPTIBILITY TESTING METHODS

9.5 Antimicrobial Resistance

1/30/ Division of Disease Control and Health Protection. Division of Disease Control and Health Protection

WHO laboratory-based global survey on multidrug-resistant organisms (MDROs) in health care interim analysis

5/4/2018. Multidrug Resistant Organisms (MDROs) Objectives. Outline. Define a multi-drug resistant organism (MDRO)

Bacterial infections complicating cirrhosis

9.4 Antimicrobial Resistance

New Drugs for Bad Bugs- Statewide Antibiogram

2015 Antibiotic Susceptibility Report

Dr Neeraj Goel Sr. Consultant Department of Clinical Microbiology. Sir Ganga Ram Hospital

Multidrug-Resistant Organisms: How Do We Define them? How do We Stop Them?

2016 Antibiotic Susceptibility Report

FIS Resistance Surveillance: The UK Landscape. Alasdair MacGowan Chair BSAC Working Party on Antimicrobial Resistance Surveillance

03/09/2014. Infection Prevention and Control A Foundation Course. Talk outline

Background and Plan of Analysis

Antimicrobial Stewardship/Statewide Antibiogram. Felicia Matthews Senior Consultant, Pharmacy Specialty BD MedMined Services

Surveillance for Antimicrobial Resistance and Preparation of an Enhanced Antibiogram at the Local Level. janet hindler

CONTAGIOUS COMMENTS Department of Epidemiology

Suggestions for appropriate agents to include in routine antimicrobial susceptibility testing

Routine internal quality control as recommended by EUCAST Version 3.1, valid from

Antimicrobial resistance (EARS-Net)

Mechanism of antibiotic resistance

Antimicrobial Resistance Prevention (Action Package: Prevent-1) Putting AMR on the priority list: Sweden Dr. Nils Anders Tegnell, Director, The

Imagine. Multi-Drug Resistant Superbugs- What s the Big Deal? A World. Without Antibiotics. Where Simple Infections can be Life Threatening

PRACTIC GUIDELINES for APPROPRIATE ANTIBIOTICS USE

EUCAST recommended strains for internal quality control

The Basics: Using CLSI Antimicrobial Susceptibility Testing Standards

Mono- versus Bitherapy for Management of HAP/VAP in the ICU

Recommendations for Implementation of Antimicrobial Stewardship Restrictive Interventions in Acute Hospitals in Ireland

Mercy Medical Center Des Moines, Iowa Department of Pathology. Microbiology Department Antibiotic Susceptibility January December 2016

ECDC-EFSA-EMA Joint Opinion on Outcome Indicators on Surveillance of Antimicrobial Resistance and Use of Antimicrobials

جداول میکروارگانیسم های بیماریزای اولویت دار و آنتی بیوتیک های تعیین شده برای آزمایش تعیین حساسیت ضد میکروبی در برنامه مهار مقاومت میکروبی

Service Delivery and Safety Department World Health Organization, Headquarters

Antimicrobial Susceptibility Patterns

Recommendations on Surveillance of Antimicrobial Resistance in Ireland

Hospital Acquired Infections in the Era of Antimicrobial Resistance

TECHNICAL REPORT External quality assessment of laboratory performance European Antimicrobial Resistance Surveillance Network (EARS-Net), 2017

Rise of Resistance: From MRSA to CRE

CONTAGIOUS COMMENTS Department of Epidemiology

2010 ANTIBIOGRAM. University of Alberta Hospital and the Stollery Children s Hospital

Antimicrobial susceptibility

Compliance of manufacturers of AST materials and devices with EUCAST guidelines

Infection Prevention Highlights for the Medical Staff. Pamela Rohrbach MSN, RN, CIC Director of Infection Prevention

a. 379 laboratories provided quantitative results, e.g (DD method) to 35.4% (MIC method) of all participants; see Table 2.

EUCAST 2010 Why European breakpoints?

Compliance of manufacturers of AST materials and devices with EUCAST guidelines

AMR epidemiological situation: ECDC update

ESCMID Online Lecture Library. by author

Childrens Hospital Antibiogram for 2012 (Based on data from 2011)

Main objectives of the EURL EQAS s

Antibiotic Resistance in India

Infectious Disease: Drug Resistance Pattern in New Mexico

2017 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose

Aberdeen Hospital. Antibiotic Susceptibility Patterns For Commonly Isolated Organisms For 2015

Dr Kamini Walia Indian Council of Medical Research

Taiwan Surveillance of Antimicrobial Resistance (TSAR)

11/22/2016. Hospital-acquired Infections Update Disclosures. Outline. No conflicts of interest to disclose. Hot topics:

UNDERSTANDING THE ANTIBIOGRAM

Interpreting Microbiology reports for better Clinical Decisions Interpreting Antibiogrammes

2015 Antibiogram. Red Deer Regional Hospital. Central Zone. Alberta Health Services

CONTAGIOUS COMMENTS Department of Epidemiology

Two (II) Upon signature

Antibiotic. Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting

Antibacterial Resistance In Wales

What is the problem? Latest data on antibiotic resistance

2009 ANTIBIOGRAM. University of Alberta Hospital and the Stollery Childrens Hospital

Einheit für pädiatrische Infektiologie Antibiotics - what, why, when and how?

Report on Antimicrobial Use and Resistance in Humans in 2012

Southern African Journal of Infectious Diseases Antimicrobial Resistance Surveillance in the South African Private Sector, Report for 2016

BactiReg3 Event Notes Module Page(s) 4-9 (TUL) Page 1 of 21

Antimicrobial Stewardship Strategy: Antibiograms

2016 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose

Microbiology. Multi-Drug-Resistant bacteria / MDR: laboratory diagnostics and prevention. Antimicrobial resistance / MDR:

DR. MICHAEL A. BORG DIRECTOR OF INFECTION PREVENTION & CONTROL MATER DEI HOSPITAL - MALTA

Antimicrobial Susceptibility Testing: The Basics

Transcription:

System for early warning and national surveillance of antimicrobial resistance! Gunnar Kahlmeter Clinical microbiology Växjö, Sweden

Early warning for antimicrobial resistance Local level (laboratory uptake area) easy to achieve with good laboratory software systems. National level many different computer systems; more difficult to achieve technically agreements on ownership more problematic than techniques to collect data Early warning requires realtime connection between host (central computer) and guests (local laboratory systems). Global level national and international networks of CDC s

Early warning against Especially unwanted phenotypes local level, national level, global defined locally and nationally Predefined threshold levels of resistance Outbreaks (local) Trends (software to pick up trends) local and national Laboratory errors (QC of database) individual laboratories

Especially unwanted phenotypes examples from history MRSA (late 60ies/70ies) N. meningitidis with Sul-resistance (70ies: from 0.01 % - 70 %) N. gonorrhoeae with betalactamase production (mid 70ies) H.influenzae with betalactamase production (mid 70ies) S.pyogenes with erythromycin resistance (ERGAS) S. pneumoniae with penicillin resistance (80ies) MRSA (early 90ies) ESBL producers (90ies) VRE (90ies) MDRTB (90ies) Exceptional MDR (multidrug resistance) (90ies) Acinetobacter, Pseudomonas MBL, KPC, NDM (2000ies)

Especially unwanted phenotypes Current candidates are dependant on prevalens MRSA single incidents / outbreak detection? Some countries (NL, SE, DK, N, SF), individual hospitals, individual wards, still have very low MRSA levels. ESBLs outbreak detection? Individual wards, neonatal dpts, ICU VRE outbreak detection? KPC single incidents / outbreak detection. MBL/NDM single incidents / outbreak detection MDRTB single incidents / outbreak detection Exceptional multiresistance single incidents

Svebar Swedish antimicrobial resistance early warning and surveillance system Gunnar Kahlmeter, SMI and Växjö Tomas Söderblom, SMI Johan Struwe, SMI Karin Tegmark-Wisell, SMI Katarina Skärlund, SMI

SVEBAR

Svebar two components 1. Early warning (EW) 2. Antimicrobial resistance suveillance Automatic (but avoid pre-mapping) Deal early with proprietory issues who owns data, how to publish, Offer benefits to participating laboratories

Svebar Sweden 9 miljon inhabitants SMI (Smittskyddsinstitutet) 25 laboratories (clinical microbiology) 5-6 different IT systems For each IT system a programme which exports all bacteriological culture-data in a structured XML-file, organised - DATA-ID (laboratory ID; not patient ID) - DATE of SAMPLE ADMISSION - TYPE OF ANALYSIS (Blood culture, Urin culture etc) - SPECIES (or if no species: NEGATIVE) - ANTIBIOTIC (disk) - AST RESULT: SIR (ZONE and/or MIC)

Export, import, export and import 25 labs export the last 14 days of culture results at 00.30 The 25 files are imported by Svebar (between 2 6 in the morning). Each file goes through the CENTRAL and the LOCAL early warning exceptional phenotype trapping system. Data is deposited in the surveillance database but only data belonging to the 14th day. CENTRAL and LOCAL reports are built and exported and then imported by each of the 25 laboratories.

Early warning Svebar exceptional antimicrobial resistance (spectacular phenotypes) Committee defines and reviews definitions of exceptional phenotypes for early warning. Communication between central and local on hits Antimicrobial resistance suveillance national comprehensive database of all culture data Laboratory, sample ID (number), date. Patient: age, gender, geographical area (county, hospital code) Type of sample/analysis (blood/culture, urine/culture etc) Species Antimicrobial (zone, MIC and interpretations SIR)

Svebar Early Warning

Svebar Daily Central Report (to SMI): Summarise all exceptional phenotypes Allows communication between Central and Local Daily Local Report Lists the local contribution to the exceptional phenotypes report Lists locally defined phenotypes of local interest (each lab can define their own EW traps)

---------------- SUMMARY ---------------- Total number of registrations: 373221 Number of negative registrations: 233354 (62%) Numbers of registrations last 24 hours: SE100 : 0 SE110 : 227 SE120 : 2573 SE230 : 127 SE240 : 181 SE250 : 202 SE300 : 0 SE310 : 0 SE320 : 0 SE450 : 0 SE540 : 59 SMI001 : 0 TOTAL : 3369 -------------- ALERT: There are items in correction list ALERT: There are one or more warnings

Central filter ID: 195 Lab : All Species : STAPHYLOCOCCUS AUREUS Antib. : VANKOMYCIN OR TEICOPLANIN OR DAPTOMYCIN OR LINEZOLID NOO : 1 %R : N/A %(R+I) : N/A Period : 14 days Triggers: none Central filter ID: 199 ------------ Filter Analysis ------------ Lab : All Species : ENTEROCOCCUS FAECIUM Antib. : VANKOMYCIN OR TEICOPLANIN NOO : 1 %R : N/A %(R+I) : N/A Period : 14 days Triggers: 2 ------------ Date :20111123 Lab :SE240 Sample date :20111111 Ident :See report-file. Date :20111123 Lab :SE240 Sample date :20111111 Ident :See report-file.

Central filter ID: 206 Lab : All Species : ESCHERICHIA COLI Antib. : ERTAPENEM OR IMIPENEM OR MEROPENEM OR DORIPENEM NOO : 1 %R : N/A %(R+I) : N/A Period : 14 days Triggers: None

Central filter ID: 207 Lab : All Species : KLEBSIELLA PNEUMONIAE Antib. : ERTAPENEM OR DORIPENEM OR IMIPENEM OR MEROPENEM NOO : 1 %R : N/A %(R+I) : N/A Period : 14 days Triggers: 2 ------------------------------ Date :20111124 Lab :SE230 Sample date :20111109 Ident :See report-file. Date :20111124 Lab :SE230 Sample date :20111109 Ident :See report-file.

Early warning Svebar exceptional antimicrobial resistance (spectacular phenotypes) Committee defines EW phenotypes Communication between central and local on hits Antimicrobial resistance suveillance national comprehensive database of all culture data Laboratory, sample ID (number), date. Patient: age, gender, geographical area (county, hospital code) Type of sample/analysis (blood/culture, urine/culture etc) Species Antimicrobial (zone, MIC and interpretations SIR)

Svebar AMR database

E. coli in urine

Algorithms for susceptibility testing are common in clinical microbiology E.coli in urine sample routine AST: Amoxicillinclavulanate Trimethoprim or Trimethoprimsulfa Quinolone Nitrofurantoin Pivmecillinam (in some countries) If 3 R s extend next day with: Aminoglycoside 3rd gen cephalosporine Carbapenem or something similar

Associated resistance

E. coli in urine

When? 8 laboratories online since up to 2 years + 10 more during 2012-13 All labs 2014 Cost per lab: 5 000 10 000

Thank you